Achalasia

Achalasia is a rare disorder of the esophagus characterized by impaired motility and the inability of the lower esophageal sphincter (LES) to relax properly during swallowing. This condition leads to difficulties in swallowing (dysphagia), regurgitation of food, and chest pain. The disorder results from degeneration of the neurons in the esophageal wall, particularly the inhibitory neurons that regulate LES relaxation and esophageal peristalsis, disrupting coordinated muscle movements necessary for effective swallowing.

The exact cause of achalasia remains unknown, but it is believed to involve autoimmune mechanisms, genetic factors, and potential viral triggers. It typically presents in middle-aged or older adults and affects both genders, though some variations exist.

Diagnosis primarily involves esophageal manometry, which measures muscle contractions and LES pressure. Barium swallow radiographs may reveal a characteristic "bird-beak" appearance at the distal esophagus, indicating a narrowed LES. Endoscopy is also used to exclude other causes of dysphagia, such as tumors.

Treatment aims to relieve symptoms by decreasing LES pressure and improving esophageal emptying. Common approaches include pneumatic dilation, where a balloon is used to stretch the sphincter, and pharmacologic agents such as nitrates or calcium channel blockers to relax the LES. Surgical options, such as laparoscopic Heller myotomy, involve cutting the muscle fibers of the LES to facilitate swallowing. Recently, minimally invasive procedures like peroral endoscopic myotomy (POEM) have gained popularity.

While achalasia is a chronic condition, proper management can significantly improve quality of life. However, patients are at increased risk for aspiration and esophageal dilation or certain types of esophageal cancer, necessitating ongoing monitoring and care.